首页> 外文OA文献 >PCN125 Impact Of Enzalutamide or Abiraterone Acetate + Prednisone (Abp) on Quality Of Life (Qol) In The Treatment of Metastatic Castration-Resistant Prostate Cancer (mcrpc) That Has Progressed on Or After Doxetaxel: A Comparative Effectiveness Study

【2h】

PCN125 Impact Of Enzalutamide or Abiraterone Acetate + Prednisone (Abp) on Quality Of Life (Qol) In The Treatment of Metastatic Castration-Resistant Prostate Cancer (mcrpc) That Has Progressed on Or After Doxetaxel: A Comparative Effectiveness Study

机译：恩扎鲁胺或醋酸阿比特龙+泼尼松（Abp）对多西他赛或其后进展的转移性去势抵抗性前列腺癌（mcrpc）的治疗对生活质量（Qol）的影响：比较有效性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cella D.; Ivanescu C.; Phung D.; Mansbach H.; Holmstrom S.; Naidoo S.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study [J] . Thiery-Vuillemin Antoine, Poulsen Mads Hvid, Lagneau Edouard, European urology . 2020,第3期

机译：AbiraTerone醋酸盐加上泼尼松或苯甲醛对转移阉割前列腺癌患者患者报告的结果的影响：来自观察水瓶座研究的最终12-Mo分析
2. Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison [J] . Pui S. Tan, Benjamin Haaland, Alberto J. Montero, Clinical Medicine Insights: Oncology . 2014,第8期

机译：激素疗法恩扎鲁胺和醋酸阿比特龙治疗多西他赛后转移性去势抵抗性前列腺癌（mCRPC）—间接比较
3. Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study [J] . Martin Boegemann, Sara Khaksar, Guillaume Bera, BMC Cancer . 2019,第1期

机译：AbiraTerone醋酸盐加上泼尼松用于管理转移性阉割前列腺癌（MCRPC）未经使用的化疗：从大型，国际，真实世界的回顾性队列研究中报告
4. The Impact of Heterogeneity of Treatment Effect on Survival, Cost Effectiveness, and Coverage of Androgen Deprivation Therapy in Metastatic Prostate Cancer [D] . Aly, Abdalla 2015

机译：异质性对转移性前列腺癌生存率，成本效益和雄激素剥夺疗法覆盖率的影响
5. A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide [O] . D.P. Petrylak, U.N. Vaishampayan, K.R. Patel, 2021

机译：含镭-223二氯化钠或与AbiraTerone醋酸盐/泼尼松或苯甲酸丁酰胺组合处理的转移阉割抗性前列腺癌（MCRPC）的量化骨扫描响应的随机相IIA研究
6. A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide [O] . D.P. Petrylak, U.N. Vaishampayan, K.R. Patel, 2021

机译：含镭-223二氯化钠或与AbiraTerone醋酸盐/泼尼松或苯甲酸丁酰胺组合处理的转移阉割抗性前列腺癌（MCRPC）的量化骨扫描响应的随机相IIA研究

PCN125 Impact Of Enzalutamide or Abiraterone Acetate + Prednisone (Abp) on Quality Of Life (Qol) In The Treatment of Metastatic Castration-Resistant Prostate Cancer (mcrpc) That Has Progressed on Or After Doxetaxel: A Comparative Effectiveness Study

著录项

引文网络

相似文献

相关主题

期刊订阅